In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe
2007 ◽
Vol 51
(9)
◽
pp. 3420-3424
◽
Keyword(s):
Group A
◽
ABSTRACT The in vitro activity of telavancin was tested against 620 gram-positive isolates. For staphylococci, MICs at which 50 and 90% of isolates were inhibited (MIC50 and MIC90) were both 0.25 μg/ml, irrespective of methicillin resistance. MIC50 and MIC90 were 0.25 and 0.5 μg/ml for vancomycin-susceptible enterococci and 1 and 2 μg/ml for vancomycin-resistant enterococci, respectively. Streptococcus pneumoniae, group A and B beta-hemolytic streptococci, and viridans streptococci were inhibited by ≤0.12 μg/ml.
2000 ◽
Vol 44
(5)
◽
pp. 1370-1374
◽
2005 ◽
Vol 49
(9)
◽
pp. 3933-3936
◽
2007 ◽
Vol 29
(2)
◽
pp. 191-196
◽
1999 ◽
Vol 34
(2)
◽
pp. 119-122
◽
1998 ◽
Vol 30
(2)
◽
pp. 89-92
◽
2000 ◽
Vol 38
(3)
◽
pp. 177-179
◽
2005 ◽
Vol 49
(6)
◽
pp. 2498-2500
◽
Keyword(s):
2000 ◽
Vol 44
(12)
◽
pp. 3447-3450
◽